Covaxin Boasts Excellent Safety Record Amid Study Highlighting Adverse Events, Says Bharat Biotech
Bharat Biotech has reaffirmed the safety of its COVID-19 vaccine, Covaxin, following a recent study that reported a significant incidence of adverse events of special interest (AESI) among participants. The company, which